Molecular Basis of a Yeast Prion Species Barrier  by Santoso, Alex et al.
Cell, Vol. 100, 277±288, January 21, 2000, Copyright 2000 by Cell Press
Molecular Basis of a Yeast Prion Species Barrier
a species barrier limits PrPSC derived from one speciesAlex Santoso,* Peter Chien,*²§ Lev Z. Osherovich,*§
and Jonathan S. Weissman*³ from infecting another preventing, for example, the
transmission of scrapie from sheep to man (Prusiner et*Departments of Cellular & Molecular
Pharmacology, and Biochemistry & Biophysics al., 1998). The recent description of variant Creutzfeld-
Jacob disease, however, suggests that in rare instances²Graduate Group in Biophysics
University of California, San Francisco bovine prions can cross the species barrier to infect
humans. Extensive transgenic mouse and chimera anal-San Francisco, California 94143-0450
yses indicate that the species barrier is largely due to
differences in sequence of the prion proteins. However,
the extent to which the species barrier is mediated bySummary
direct interaction between prion particles as opposed
to species-specific interactions with cellular factors isThe yeast [PSI1] factor is inherited by a prion mecha-
unresolved (Kocisko et al., 1995; Telling et al., 1995).nism involving self-propagating Sup35p aggregates.
Even in nonprion amyloid diseases, the ability of amy-We find that Sup35p prion function is conserved
loids to incorporate other types of protein has beenamong distantly related yeasts. As with mammalian
implicated in the disease process (Han et al., 1995),prions, a species barrier inhibits prion induction be-
although other studies have failed to observe cross-tween Sup35p from different yeast species. This bar-
seeding between different amyloid-forming peptidesrier is faithfully reproduced in vitro where, remarkably,
(Come et al., 1993).ongoing polymerization of one Sup35p species does
The prion-like phenomenon [PSI1] of Saccharomycesnot affect conversion of another. Chimeric analysis
cerevisiae offers a powerful system to study the molecu-identifies a short domain sufficient to allow foreign
lar basis of amyloid propagation and specificity. Identi-Sup35p to cross this barrier. These observations argue
fied as a non-Mendelian trait that confers suppressionthat the species barrier results from specificity in the
of nonsense mutations, [PSI1] arises from conversiongrowing aggregate, mediated by a well-defined epi-
of the translational termination factor Sup35p from atope on the amyloid surface and, together with our
soluble and active state into an insoluble and inactiveidentification of a novel yeast prion domain, show that
amyloid (Wickner et al., 1995; Lindquist, 1997). The abil-multiple prion-based heritable states can propagate
ity of Sup35p amyloids to incorporate newly made solu-independently within one cell.
ble proteins is thought to be the basis of [PSI1] propaga-
tion. As Sup35p aggregation increases translationalIntroduction
readthrough, the presence of the [PSI1] prion can be
readily monitored.Amyloid protein aggregates have been increasingly im-
To investigate the requirements for prion formationplicated in human diseases, including prion-based en-
and amyloid specificity and to examine if there is evolu-cephalopathies, noninfectious neurodegenerative dis-
tionary pressure to retain prion function, we cloned andeases, and systemic amyloidoses (Koo et al., 1999).
characterized Sup35p from a spectrum of Saccharomy-Amyloids are b sheet rich, ordered structures consisting
cetales (budding yeasts). Interestingly, we find that theof protofibrils (Sunde and Blake, 1997) that coalesce in
ability to support a prion mechanism of inheritance isvitro to form extended fibrils that bind the dye Congo
broadly conserved. Moreover, as with mammalian pri-red. Fibrils are also found under some conditions in vivo,
ons, a species barrier prevents cross-species prion in-although their role in pathogenesis remains unresolved
duction. We have taken advantage of these phenomena(Lansbury, 1999). Despite having similar aggregated
to elucidate the requirements for prion formation andstructures, sequence comparison of amyloidogenic pro-
the molecular basis of this species barrier.teins fails to reveal any obvious similarities.
A striking property of most amyloids is the ability to
catalyze their own propagation. In prion diseases, this Results
self-propagation is thought to be the basis of protein-
mediated infectivity. Here, the abnormal b sheet±rich The Prion Domain Is Conserved in Yeast Evolution
The N terminus of Sup35p is necessary and sufficientprion form (PrPSC) can convert the normal cellular a-helical
protein (PrPC) into the prion isoform (reviewed in Prusiner for prion formation and propagation. This prion domain
(PrD) is connected to the C-terminal translation termina-et al., 1998). Even in the noninfectious amyloid diseases,
such as Alzheimer's disease, amyloid self-propaga- tion domain (EF) by a highly charged middle domain
(M) of unknown function (Ter-Avanesyan et al., 1993).tion may be critical to disease progression (Lansbury,
1999). Deletion of the PrD allows Sup35p to remain soluble
and functional even in [PSI1] yeast, whereas transientStudies of the mammalian prion have highlighted the
importance of specificity in amyloid propagation. Here, overexpression of this domain induces conversion of
[psi2] yeast to [PSI1] (Patino et al., 1996; Paushkin et
al., 1996). Mutational analyses have begun to define the³ To whom correspondence should be addressed (e-mail: jsw1@
sequence requirements for prion formation and propa-itsa.ucsf.edu).
§ These authors contributed equally to this work. gation (DePace et al., 1998; Liu and Lindquist, 1999).
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Although the PrD is generally tolerant to amino acid from C. albicans, K. lactis, and P. methanolicaÐdenoted
PrDMCA, PrDMKL, and PrDMPM, respectivelyÐconferredchanges, several unusual features were found to be
antisuppression to [PSI1] cells, suggesting that they areimportant. In particular, it has a high glutamine (Gln) and
not inactivated by the endogenous S. cerevisiae ag-asparagine (Asn) and low charge content. In addition,
gregate.the PrD has a set of imperfect oligopeptide repeats,
In the visual assay, the in vivo aggregation state isdeletion and expansion of which modulate its ability to
observed directly using an inducible PrDM fused to GFPinduce the conversion to [PSI1].
(Patino et al., 1996). As expected, upon PrDMSC-GFPTo determine whether these features are conserved,
induction, punctate foci appear rapidly in the majoritywe cloned and characterized Sup35p PrDs from a variety
of [PSI1] cells (Figures 2B and 2C). In contrast, [psi2]of yeasts. Taking advantage of the conservation of the
cells show a prolonged diffuse cytoplasmic fluores-EF domain, we used one-sided PCR (Frohman, 1993)
cence, with foci forming slowly. Expression of the fusionas well as available SUP35 sequences (Kushnirov et al.,
of the N-terminal regions of C. albicans, K. lactis, and1990) to clone sequences upstream of this region. In
P. methanolica to GFP also resulted in formation of foci.total, we examined SUP35 genes from seven non±S.
Indeed, de novo formation of foreign PrDM foci in [psi2]cerevisiae budding yeast species (Candida albicans,
cells, especially of PrDMPM-GFP, is faster than that ofKluyveromyces lactis and marxianus, Pichia metha-
S. cerevisiae PrDM. In contrast to PrDMSC-GFP, how-nolica and pastoris, Saccharomycodes ludwigii, and Zy-
ever, the in vivo kinetics of foreign PrDM aggregationgosaccharomyces rouxi) (Figure 1A).
are similar in [psi2] and [PSI1] cells (Figure 2C). Together,Significantly, all of the Sup35 proteins examined have
these assays show that although the ability of theseN-terminal regions similar in composition to the PrD and
PrDs to aggregate is conserved, the foreign prion do-M domains of the S. cerevisiae protein (Figures 1B and
mains are not incorporated into the endogenous Sup35p1C). Although there is little exact sequence homology,
aggregate present in [PSI1] yeast.all of the PrDs have a high Gln/Asn (36% to 43%) and
Conversely, we asked if foreign PrD aggregates coulda low charge (2% to 10%) content. This composition
incorporate soluble S. cerevisiae Sup35p present inresembles that of a modular prion domain from another
[psi2] yeast. Aggregates formed by transient overex-S. cerevisiae prion protein, Ure2p (Edskes et al., 1999),
pression of PrDMSC, either by itself or fused to GFP,but is very different from that of full-length proteins from
incorporate native full-length Sup35p, leading to a per-the S. cerevisiae genome, which have on average 9%
manent conversion to [PSI1] (Chernoff et al., 1993; Pat-Gln/Asn and 23% charged residues (Figure 1B). Finally,
ino et al., 1996). After 24 hr of induction, z1.5% of [psi2]the imperfect oligopeptide repeats of QGGYQQYN,
cells convert to [PSI1] (Figure 2D). In contrast, similaralthough highly divergent, are clearly detectable (Fig-
levels of overexpression of foreign PrDM-GFPs, even ature 1C).
timepoints when foci are readily observable, fail to in-
duce [PSI1] conversion (Figure 2D and inset). Thus, theForeign PrDs Aggregate, but Do Not Interact
foreign PrD aggregates are unable to seed the in vivowith S. cerevisiae Sup35p
aggregation of S. cerevisiae Sup35p.
The unusual sequence composition common to all
Hereafter, we designate the aggregation state of the
Sup35p N-terminal domains prompted us to examine if
foreign PrDs by [CHI]. For example, in [psi2 CHI1] yeast,
the ability to support prion-based inheritance is also endogenous Sup35p is soluble and the foreign PrD is
conserved. Focusing on C. albicans, K. lactis, and P. aggregated, whereas in [psi2 chi2] yeast, both the en-
methanolica, we asked whether the foreign Sup35p N-ter- dogenous and foreign Sup35p are soluble.
minal domains could be recruited efficiently into the
S. cerevisiae [PSI1] aggregate using both functional and Foreign PrDs Form Stable Prions that Are Limited
visual assays. In the functional assay, foreign PrDM by a Species Barrier
fused to S. cerevisiae EF domain, termed PrDM-EF, is Given the long evolutionary distance separating these
ectopically expressed in the [PSI1] yeast. The PrDM- yeast species, the failure of the foreign PrDs to interact
EF gene is under control of the S. cerevisiae SUP35 with S. cerevisiae prions is not surprising, but leaves
promoter, resulting in a moderate, constitutive level of unresolved the question of whether the foreign PrDs
expression. If the foreign PrDs were not incorporated in behave as prions. To address this question, we devised
the endogenous [PSI1] aggregate, soluble fusion protein a novel genetic system that allowed us to monitor the
would provide functional translation termination activity, induction and propagation of [CHI1] (Figure 3A). Here,
thereby leading to an antisuppressed phenotype. This two plasmids were introduced into yeast. The first,
can be phenotypically monitored by use of yeast harbor- termed the maintainer plasmid, encodes an HA epitope±
ing an ade-1 marker with a suppressible nonsense muta- tagged PrDM-EF fusion protein under control of the S.
tion (Chernoff et al., 1995). In suppressed yeast, func- cerevisiae SUP35 promoter. The second inducer plas-
tional Ade1p is produced, resulting in white colonies mid encodes a PrDM-GFP fusion protein under control
on low adenine medium and growth on adenine-free of the inducible CUP1 promoter. Transient overexpres-
medium. By contrast, the lack of functional Ade1p in sion of the inducer protein, either from the same (homo-
either [psi2] or antisuppressed [PSI1] yeast results in typic) or different (heterotypic) species as the maintainer
red colonies on low adenine and lack of growth on ade- PrD, results in de novo formation of the GFP fusion
nine-free media. As expected, when S. cerevisiae PrDM aggregates, thus mimicking infection experiments used
(PrDMSC) was used in the fusion protein, [PSI1] yeast in studies of mammalian prions. The ability of the inducer
retained the suppression phenotype (Figure 2A). In con- aggregates to ªinfectº the maintainer PrD is monitored
by the permanent change in suppression phenotype.trast, expression of fusion proteins containing PrDMs
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Figure 1. Evolutionary Analysis of Sup35p PrDs
(A) Phylogenetic relationship of yeast species based on 26S RNA sequences (Kurtzman, 1994). For comparison, the fission yeast S. pombe,
whose Sup35p does not have a PrD (Ito et al., 1998), is shown. Scale (percent divergence) is denoted on top. Resende et al. have previously
submitted a full-length sequence of SUP35 from C. albicans (AF020554) to public databases.
(B) Plot of percent of charged (Arg, Lys, Asp, Glu) versus Gln/Asn residues for the Sup35 PrD homologs as well as the S. cerevisiae Ure2p
prion domain. For comparison, the full-length S. cerevisiae ORFs, including specifically the entire Sup35p and Ure2p proteins are also shown.
(C) Amino acid sequence comparison of PrD homologs. Amino acid identities and similarities are indicated by dark gray and light gray boxes,
respectively. Sequences were aligned using the ClustalW algorithm (Higgins et al., 1996). The black bar denotes the approximate location of
the oligopeptide repeats. The GenBank accession numbers are as follows: Z. rouxii, AF206292; S. ludwigii, AF206291; P. pastoris, AF206290;
K. marxianus, AF206289; K. lactis, AF206288; C. albicans, AF206287.
This system allowed us to test whether the foreign resulted in z7.5% adenine-prototrophic [PSI1 CHICA1]
colonies (Figure 3B). By contrast, less than 0.005%PrD aggregates behave as prions, and if so, whether
divergence in sequences leads to a species barrier to [chiCA2] cells were converted when an empty control
plasmid or any of the heterotypic inducers were used.prion propagation (Figure 3A). In support of the species
barrier model, we found that the conversion of the main- Likewise, in the presence of PrDMKL-EF and PrDMPM-EF
maintainers, only the overexpression of the homotypictainer PrD is induced only upon overexpression of the
homotypic inducer PrD. For example, overexpression inducers caused efficient conversion to the [CHI1] state.
Finally, double fluorescence experiments using fusionsof PrDMCA-GFP in the presence of PrDMCA-EF maintainer
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Figure 2. Examination of the Ability of Foreign PrDs to Interact with S. cerevisiae PrD
Throughout the figures CA, KL, PM, and SC refer to PrDMCA, PrDMKL, PrDMPM, and PrDMSC, respectively. c1 and c2 indicate the presence or
absence of the S. cerevisiae PrD aggregate. x1 and x- indicate the presence or absence of the foreign PrDM aggregates. All quantitative
experiments were conducted in triplicate and errors are indicated.
(A) Effect of foreign PrDM-EF fusion proteins on the [PSI1] suppression phenotype. [PSI1] yeast expressing the indicated species of PrDM-
EF fusion were plated on low or no ADE medium. For comparison, [psi2] yeast are also shown. On top is shown a schematic model explaining
the antisuppression phenotype (red colonies on low ADE and lack of growth on no ADE) resulting from expression of foreign PrDM. In [psi2]
cells, soluble Sup35p mediates translational termination at the ade1 nonsense mutation (red bar). In suppressed [PSI1] yeast, absence of
soluble Sup35p results in translational readthrough. Failure of foreign PrDM-EF to be incorporated into the [PSI1] amyloid leads to soluble
EF and antisuppression.
(B) Illustration of GFP visual assay. On top is shown a schematic of the copper-inducible PrDM-GFP plasmid. From left to right are examples
of diffuse GFP fluorescence in [psi2] cells, discrete foci in [PSI1] cells and de novo aggregates formed by overexpression of PrDMCA-GFP,
and PrDMPM-GFP as observed by fluorescence microscopy.
(C) Quantitative foci formation kinetics. [PSI1] and [psi2] yeast, as indicated, containing either PrDMSC-GFP (left) or the indicated foreign PrDM-
GFP (right) were induced in early log phase, and results are plotted as the percentage of fluorescent cells with visible foci as a function of
induction time.
(D) Induction of [PSI1] by overexpression of PrDM-GFP. [psi2] yeast containing a plasmid encoding the indicated species of PrDM-GFP or
an empty control plasmid were plated on media lacking adenine either before (uninduced) or after 24 hr of copper induction. The number of
[PSI1] colonies (CFUs) per 105 cells is plotted. (Inset) Immunoblots of inducer PrDM expression following induction.
between PrDM and two color variants of GFP showed The reversible loss of the [PSI1] factor, by overexpres-
sion of the molecular chaperone HSP104 or by exposurethat prion aggregates from two different PrD species do
not colocalize (Figure 3C). to guanidine hydrochloride, provided critical evidence
that [PSI1] inheritance is mediated by a change in proteinWe next asked whether the [CHI1] prion state could
propagate stably. [PSI1 CHI1] yeast were sequentially conformation rather than by a DNA element (Wickner,
1994; Chernoff et al., 1995). HSP104 overexpression andpatched onto medium that selects for the maintainer
plasmid but not for the inducer plasmid or the prion guanidine caused solubilization of the [CHICA1] aggre-
gate, suggesting that both [CHI1] and [PSI1] prions arestate. Interestingly, some [PSI1 CHI1] isolates rapidly
reverted back to unsuppressed [chi2] state, whereas cured by similar mechanisms (Figure 3E and data not
shown). Furthermore, the [CHICA1] prion can propagateother strains propagated the [CHI1] aggregate robustly.
After three successive patches, corresponding to z60 even in yeast lacking the endogenous sup35 gene (Fig-
ure 3F). As with [PSI1 CHI1] yeast, transient exposuregenerations, a typically strong [PSI1 CHICA1] strain had
lost the inducer plasmid but could still grow on medium to guanidine also cures the [CHI1] state. Together, these
data provide strong genetic evidence that foreign PrDslacking adenine. Even more remarkably, no red sectors
were observed on low adenine media, demonstrating can support prion-based inheritance and that a barrier
prevents cross-seeding between different species ofPrDs.that even in the absence of selection, yeast uniformly
retained the [CHI1] prion (Figure 3D). Using a centrifugation assay (Patino et al., 1996;
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Figure 3. Examination of the Ability of Homotypic or Heterotypic PrD Overexpression to Induce [CHI1] Prions
(A) Schematic of [CHI1] two-plasmid induction assay. Expression of foreign PrDM-EF from the maintainer plasmid in [PSI1 chi2] cells results
in soluble EF activity, leading to antisuppression. Aggregates are introduced by transient overexpression of the PrDM-GFP fusion either from
the same (homotypic) or different (heterotypic) species as the maintainer. The ability of the introduced aggregates to convert the PrDM-EF
fusion yielding [PSI1 CHI1] yeast can be monitored by a persistent change in suppression phenotype. Below, for each of the three indicated
models, the predicted effect of homotypic and heterotypic inducers on [CHI1] conversion is shown.
(B) Induction of [CHI1] by overexpression of homotypic and heterotypic PrDM-GFP inducers. [PSI1 chi2] yeast containing HA epitope±tagged
C. albicans, P. methanolica, or K. lactis maintainer plasmid indicated by CA-EF, PM-EF, and KL-EF, respectively, and the indicated inducer
plasmid were grown in selective medium to early log phase. Following 40 hr of copper induction, the number of [PSI1 CHI1] colonies (CFUs)
was determined by plating onto no ADE medium.
(C) In vivo observation of species-specific aggregation. Shown are fluorescence images of [PSI1] yeast coexpressing fusion proteins between
the indicated species of PrDM and a yellow (YFP) and cyan (CFP) variant of GFP driven by an inducible copper promoter. The left, middle,
and right panels display the cyan, yellow, and combined fluorescence, respectively. Schematics on the right indicate the identity of the PrDM-
GFP variant fusion proteins. Dotted lines denote the cell outlines.
(D) Stability of propagation of a [CHI1] prion. A robust [PSI1 CHICA1] isolate was patched serially onto complete medium. Following the indicated
number of passages, an aliquot was patched on either low or no ADE medium, as indicated, to test for the presence of the suppression
phenotype caused by [CHI1]. For comparison, [psi2] and [PSI1] yeast are shown.
(E) Centrifugation assay to examine the solubility of foreign PrDM-EF. Extracts from the indicated yeast strains were centrifuged at 100,000
g, and soluble (S) or pelleted (P) fractions were assayed by immunoblots with antibodies (a-HA) specific to the epitope-tagged PrDMCA-EF or
with antibodies (a PrDMSC) specific to the S. cerevisiae Sup35p.
(F) Formation and propagation of [CHI1] in the absence of S. cerevisiae Sup35p. A yeast strain was constructed in which the chromosomal
SUP35 gene was deleted and replaced with an episomal copy PrDMCA-EF. Shown are examples of this strain either prior to or after induction
of the [CHI1] prion, denoted [c8 x2] and [c8 x1], respectively, plated on either low or no ADE medium. For comparison [PSI1] and [psi2] yeast
are also shown.
Paushkin et al., 1996), we confirmed biochemically that largely in the supernatant both in the unconverted and
the guanidine- or HSP104-cured [chi2] strains (Figurethe [CHI1] suppression phenotype results from a herita-
ble aggregation of the foreign PrDM-EF protein. Aggre- 3E and data not shown).
gated Sup35p from [PSI1] yeast extract fractionates to
the pellet following high-speed centrifugation, whereas Selective Seeding of Fibril Formation Recapitulates
the Species Barrier In Vitrosoluble Sup35p from [psi2] yeast extract remains largely
in the supernatant. When subjected to this centrifuga- Purified Sup35p forms self-seeding amyloids in vitro,
thereby providing a simple biochemical system to exam-tion assay, PrDMCA-EF protein from [CHICA1] yeast frac-
tionates to the pellet (Figure 3E). By contrast, it remains ine the molecular basis of the observed species barrier
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species. However, for yeast to stably exist in a [PSI1
chi2] state, the foreign PrD must remain soluble in the
presence of continuous aggregation of similar levels of
the endogenous Sup35p. To better simulate this condi-
tion, we tested the effect of selective seeding of a solu-
tion containing an equal concentration of PrDMSC and
PrDMCA monomers. Addition of a small amount of
PrDMSC seed (5%) shortly after the initiation of the poly-
merization reaction caused an immediate conversion
detected by Congo red binding (Figure 5A). Consistent
with the notion that ongoing PrDMSC polymerization
does not induce conversion of PrDMCA, the curve pla-
teaus at a level corresponding to conversion of half of
the total protein. Subsequent addition of PrDMCA seed
(5%) initiated the conversion of the remaining protein.
In contrast, if no seed or more PrDMSC seed was added,
there was no immediate conversion. Instead, a slow
rise in Congo red binding was observed with kinetics
indistinguishable from that of the spontaneous conver-
sion of PrDMCA (Figure 5B).
Immunoelectron microscopy confirmed that these
two prions had a strong preference to form amyloid
fibrils composed of a single species. We used a species-
specific polyclonal antibody to label S. cerevisiae PrDM
with 5 nm gold particles and a monoclonal epitope tag±Figure 4. In Vitro Amyloid Fibril Formation of PrDMSC and PrDMCA
specific antibody to label PrDMCA with 15 nm gold. In aTo initiate conversion, concentrated pure PrDM protein in urea was
reaction where equimolar amounts of PrDMSC anddiluted into conversion buffer and subjected to continuous slow
PrDMCA were polymerized simultaneously, individual fi-rotation. At indicated times, the extent of fibril formation was as-
sayed by Congo red binding. Each curve was conducted in triplicate. brils were labeled with only one size of gold particles,
Bars indicate errors larger than the symbol size. suggesting that, as observed in vivo in the double fluo-
(A) Conversion kinetics of 2.5 mM S. cerevisiae PrDM in the absence rescence studies (Figure 3C), fibrils were composed ex-
(square) and presence of 1% (wt/wt) preformed PrDMSC (diamond) clusively of a single species of PrD (Figure 5C).and PrDMCA (circle) fibrils.
(B) Conversion kinetics of 2.5 mM C. albicans PrDM in the absence
(square) and presence of 1% (wt/wt) preformed PrDMCA (diamond) Prion Specificity Is Encoded in a Short Region
and PrDMSC (circle) fibrils. of the PrD Domain
Taking advantage of the visual and [PSI1] conversion
assays described above, we next asked whether a spe-(Glover et al., 1997; King et al., 1997; Paushkin et al.,
1997; DePace et al., 1998). After dilution of purified cific region of the PrD is responsible for the species
barrier. We created two complementary chimeric pro-PrDMSC from denaturant, there is an initial lag phase of
z120 minutes, followed by a cooperative conversion teins, the first of which (PrDMSC1-39CA) contained residues
1 to 39 from S. cerevisiae with the remaining PrD se-from random coil to b sheet±rich amyloid fibrils. This
conversion can be readily monitored by selective bind- quence from C. albicans, and the second (PrDMCA1-39SC)
in which the first 39 residues of PrDMSC were replaceding of the fibrils to the dye Congo red (Figure 4A). Impor-
tantly, the addition of preformed fibril catalyzes this con- with the C. albicans sequence (Figure 6A). Microscopic
examination of GFP fusions shows that both chimerasversion by eliminating the lag phase, thus recapitulating
in vitro the self-propagation of the prion state. form aggregates (Figure 6C and data not shown). How-
ever, while overexpression of PrDMSC1-39CA was highlyWe attempted to recapitulate [CHI1] prion propaga-
tion in vitro using purified C. albicans PrDM proteins effective at converting [psi2] yeast to [PSI1], overexpres-
sion of PrDMCA1-39SC had no detectable effect (Figure 6B).(PrDMCA). Upon dilution from denaturant, PrDMCA exhib-
ited a cooperative transition to fibrils following a lag A previous study had found that mutations that cause
poor incorporation into or curing of wild-type [PSI1] ag-phase of z140 minutes. As with PrDMSC, addition of a
small amount (1%) of preformed PrDMCA fibrils elimi- gregates cluster to a short region composed of residues
8 to 26 (DePace et al., 1998). To test whether this epitopenated the lag phase (Figure 4B). Strikingly, the addition
of PrDMCA fibrils, even at amounts that could efficiently is sufficient to allow crossing of the species barrier, we
constructed a third chimera consisting of residues 8catalyze PrDMCA amyloid formation, did not convert
PrDMSC (Figure 4A). Conversely, addition of PrDMSC seed to 26 of S. cerevisiae replacing the corresponding C.
albicans sequence, denoted PrDSC8-26CA (Figure 6A). Thisdid not alter the kinetics of PrDMCA fibril formation (Fig-
ure 4B). Thus, our in vitro seeding experiments mirror a chimeric PrDM-GFP retains the ability to aggregate and
is seeded by the endogenous Sup35p aggregate, askey aspect of the in vivo homotypic conversion experi-
ments, in which prion formation is initiated only by ho- shown by the visual assay (Figure 6C). More remarkably,
it induces conversion of [psi2] yeast to [PSI1] with onlymotypic PrD overexpression.
In the selective seeding experiments above, addition a modestly reduced efficiency (z2-fold) compared with
wild-type PrDMSC (Figure 6B). These data indicate that aof a fibril seed failed to convert PrDM from another
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short peptide epitope composed of residues 8 to 26, pre-
sumably on the growing face of the amyloid, is sufficient
to mediate specificity in the incorporation of monomers
into the polymerizing fibril (Figure 6D, see Discussion).
Identification of a Novel Prion-Forming Protein
in S. cerevisiae
The observation that all known yeast prion proteins have
high Gln/Asn content and few charged residues (Figure
1B) suggests that proteins with similar properties could
form prions. A search of genomic databases revealed
that several other proteins have domains with similar
properties (Figure 7A and M. Michelitsch and J. S. W.,
unpublished data). We experimentally examined the
ability of one such domain from a protein encoded by
the uncharacterized ORF YPL226W (NEW1) to form a
prion using the two-plasmid assay described above. We
fused the first 153 amino acids of New1p to an HA3
epitope±tagged EF domain and expressed this fusion
protein, termed New1p1±153-HA3-EF, driven by the SUP35
promoter. Initially, this fusion protein complemented the
deficiency of Sup35p activity associated with [PSI1],
indicating that it is not inactivated by the [PSI1] prion; we
termed this antisuppressed state [PSI1 nu2]. However,
transient overexpression of the same fragment fused to
GFP, but not overexpression of PrDMSC-GFP or PrDMCA-
GFP, caused z10% of [PSI1 nu2] cells to convert to a
suppressed state termed [PSI1 NU1] (Figure 7B). As
with [CHI1], we found significant variation among [NU1]
isolates, with some rapidly reverting to [nu2] and others
propagating stably (data not shown). Finally, centrifuga-
tion analysis directly demonstrated that the [NU1] state
results from aggregation of the New1p-EF fusion (Figure
7C). Taken together, these observations argue the Gln/
Asn-rich N-terminal region of New1p can support a prion
mechanism of inheritance.
Discussion
To investigate how prions can specifically propagate in
the complex cellular milieu, we have cloned and charac-
terized the N-terminal prion domain (PrD) from a range of
budding yeasts. Despite the long evolutionary distances
separating these species (Kurtzman, 1994), the Sup35p
homologs examined contain PrDs capable of forming
prions. In particular, upon induction of aggregates by
overexpression, the foreign PrDs switch from an initially
soluble [chi2] state to an aggregated [CHI1] prion state.
This prion state can stably propagate until cured by
guanidine treatment or HSP104 overexpression. As with
mammalian prions (Prusiner et al., 1998), a species bar-
rier prevents prion aggregates from one species from
converting soluble PrDs of another.
mond) twice with PrDMSC fibril (square) compared to unseeded kinet-
ics of PrDMCA (circle).
Figure 5. In Vitro Amyloid Fibril Formation of a PrDMSC/PrDMCA (C) Electron micrographs of the converted PrDMSC and PrDMCA mix-
Mixture ture. PrDMSC and PrDMCA are labeled by 5 nm and 15 nm gold
(A) Conversion kinetics of equimolar mixture (2.5 mM) of PrDMSC and particles, respectively, using species-specific antibodies. Examples
PrDMCA seeded with 5% (wt/wt) PrDMSC fibril and subsequently with of fibers decorated exclusively with 5 nm (left) or 15 nm (right) gold
PrDMCA fibril at indicated timepoints. particles from the same electron micrograph are shown. Although
(B) Conversion kinetics of an equimolar mixture (2.5 mM) of PrDMSC some fibrils were poorly labeled, no fibers were decorated by both
and PrDMCA seeded with 5% (wt/wt) PrDMSC fibril only (filled dia- antibodies. Scale bar corresponds to 100 nm.
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Figure 6. Chimeric Analysis of PrD
(A) Schematics of chimeric PrD sequences.
Residue numbers are indicated on top. Chi-
meric region residue numbers are that of S.
cerevisiae sequence. S. cerevisiae regions
are denoted by purple and C. albicans by light
yellow.
(B) Efficiency, relative to PrDMSC, of conver-
sion of [psi2] to [PSI1] by overexpression of
the indicated PrDM-GFP fusion.
(C) Quantitative foci formation kinetics. [PSI1]
and [psi2] yeast, as indicated, containing the
indicated chimeric PrDM-GFP fusion were
grown in selective medium and induced at
early log phase. Shown is a plot of the per-
centage of fluorescent cells with visible foci
as a function of induction time.
(D) Hypothetical model to explain chimera
conversion data. The N-terminal region of PrD
is envisioned as having many of the critical
species-specific interactions involved in re-
cruitment of new monomers to the growing
amyloid, whereas the C-terminal region may
be primarily involved in intramolecular inter-
actions that stabilize the prion form.
Surprisingly, even in identical genetic backgrounds, efforts (Prusiner et al., 1998). Many questions about the
molecular basis of the prion species barrier remain. Fordifferent [CHI1] isolates of the same foreign PrD species
as well as different [NU1] isolates show markedly differ- example, in vitro experiments indicate that specific inter-
actions between PrPSC and PrPC lead to a species barrierent stability and levels of nonsense suppression. Analo-
gous strain differences were found previously in [PSI1] in generating the protease-resistant form (Kocisko et
al., 1995; Horiuchi and Caughey, 1999). In vivo chimeraas well as in mammalian prions (Derkatch et al., 1996;
Prusiner et al., 1998; Zhou et al., 1999). Initially discov- analyses, however, suggest that species-dependent in-
teractions between the prion particles and an unidenti-ered as differences in pathology between isolates of
scrapie, mammalian prion strains were thought to result fied host factor, termed Protein X, also contribute sub-
from nucleic acid variations, arguing against a protein- stantially to the species barrier (Telling et al., 1995).
mediated mechanism of prion infectivity. It now appears These issues have been difficult to resolve because of
that the presence of stable, distinct strains, possibly the inability thus far either to produce de novo infectious
arising from different prion conformations, is an inherent PrPSC or to effectively recapitulate sustained prion prop-
property of prions. agation in vitro.
Our data show that for the yeast [PSI1] prion, the
species barrier results from a remarkable specificity inInsights into the Molecular Architecture of the Prion
Domain: Specificity and Stability Domains interaction between the prion protein itself, mediated
by a well-defined epitope in the PrD (Figure 6D). First,within the PrD
The mammalian prion species barrier, which prevents for all of the species examined, only overexpression
of homotypic PrD induces prion formation. Similarly,the spread of scrapie and bovine spongiform encepha-
lopathy to man, has been the focus of intense research Chernoff and coworkers have recently found that the
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Figure 7. The N Terminus of New1p Can Act
as a Prion
(A) The amino acids content of Sup35p PrD,
residues 10 to 100 of New1p, residues 230 to
319 from the C. elegans ORF CE00344, and
the first 90 amino acids of Ure2p are dis-
played. For the PrD plot, the average value
among the various yeast species is used with
error bars indicating the maximum variation.
(B) Phenotypic consequences of prion forma-
tion by the New1p1±153-HA3-EF fusion protein.
Shown are examples of [PSI1 nu2] and [PSI1
NU1] isolates grown on medium with low
amounts of adenine (above) and no adenine
(below), illustrating the conversion from an
antisuppressed to a suppressed state follow-
ing [Nu1] induction. For comparison, [PSI1]
and [psi2] strains are shown.
(C) Centrifugation assay to follow the solubil-
ity of the New1p1±153-HA3-EF fusion, per-
formed as in Figure 3E.
[PSI1] state of the endogenous S. cerevisiae Sup35p monomers. By contrast, expansion or deletion of the
imperfect oligopeptide repeats would lead to increasedcan not be transmitted by expression of heterologous P.
Methanolica Sup35p in the absence of the S. cerevisiae or decreased stabilization of the PrD, thereby modulat-
ing its tendency to form amyloids without altering prionprotein (Y. Chernoff et al., personal communication).
Second, as with [PSI1] (Tuite et al., 1981; Chernoff et specificity.
al., 1995), transient overexpression of the molecular
chaperone HSP104 or exposure to guanidine, which An Epigenetic Switch: Prion-Based
Protein Regulation?most likely acts by modulating cellular factors, cures
the [CHICA1] prion. Thus, at least for these components, Alleles of the mammalian prion protein prone to prion
formation are rare, as would be expected given the dev-the ability of the S. cerevisiae folding machinery to regu-
late the aggregation state of the C. albicans PrD is con- astating effects of these diseases. By contrast, the abil-
ity of the N-terminal domain of Sup35p to form a prionserved. Third, in vitro selective seeding experiments
faithfully recapitulate the species barrier. Strikingly, is conserved across the budding yeasts. This functional
conservation is remarkable since the PrD sequence iseven in an equimolar solution of PrDMSC and PrDMCA,
seeded polymerization of the S. cerevisiae protein leads not strongly conserved and earlier mutational analyses
showed that even single point mutations in the S. cere-to rapid formation of pure PrDMSC fibrils without affecting
the polymerization kinetics of the C. albicans protein. visiae PrD can inhibit prion formation (DePace et al.,
1998). These observations raise the intriguing possibilityFinally, chimeric analyses reveal that prion specificity
of S. cerevisiae can be conferred to the PrD of another that rather than being pathogenic, [PSI1] might be an
evolutionarily beneficial state. However, we can not rulespecies by a substitution of 19 amino acid residues near
the PrD N terminus. out the possibility that the retention of prion function
is a by-product of conservation of an unidentified PrDThis localization of a species-determining region
helps reconcile disparate results from previous efforts function (Bailleul et al., 1999). Consistent with a benefi-
cial role for the [PSI1] prion, Tuite and coworkers foundto dissect PrD function. A screen for mutant PrDs that
either fail to interact with or cause curing of the endoge- that following exposure to high temperature or ethanol,
some [PSI1] yeasts show enhanced survival comparednous [PSI1] prion found that these mutations are located
between residues 8 and 26 (DePace et al., 1998). How- to isogenic [psi2] yeasts (Eaglestone et al., 1999). In
addition, we find that overexpression of PrDMCA-GFP inever, sequences C-terminal to this region have been
shown to be critical for prion function (Doel et al., 1994; C. albicans induces formation of punctate foci, although
it remains to be seen whether these aggregates canLiu and Lindquist, 1999). Moreover, expansion of the
imperfect oligopeptide repeats, also located outside propagate in a prion-like manner (unpublished observa-
tions).of this species-determining domain, dramatically en-
hances the rate of prion formation. These observations, As a mechanism of inheritance, prions provide a num-
ber of potentially advantageous features (Lindquist,together with our in vitro selective seeding experiments,
suggest a model (Figure 6D) in which the N terminus 1997). Prion formation allows a cell to inhibit the activity
of a specific protein and propagate this state indefinitelyresides on the surface of the growing amyloid and con-
tributes much of the specificity of PrD monomer recruit- while retaining the potential to restore the original pro-
tein activity. Moreover, the rate of conversion to andment. By contrast, the more C-terminal region might
largely be involved in intramolecular interactions that from the prion state can be dramatically enhanced by
changes in the environment (Tuite et al., 1981). Finally,stabilize the prion form. Substitution of S. cerevisiae
residues 8 to 26 into PrDCA would thus change the sur- because prion domains are modular (Ter-Avanesyan et
al., 1993; Patino et al., 1996), fusion to prion domainsface of the amyloid, allowing it to incorporate PrDSC
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GACCCATGACAAGTACCA; P12, GGCCCAGTGAGCAGAGTGACGcould potentially allow prion-based regulation of a broad
GAGGACTCGAGCTCAAGCTAATCCGGCGTGCATTGAC; P13, GATrange of proteins.
CGTCAATGCACGCCGGATTTACGCC; P14, CTAATACGACTCACTFor a prion to serve as an epigenetic switch, it must
ATAGGGCTCGAGCGGCCGCCCGGGCAGGT; P15, ACCTGCCC;
propagate specifically without interfering with other pro- P16, GCGCGTCGACATGCCTCCAAAGAAGTTTAAGG; P17, GCGCC
teins. Specificity of prion interactions, resulting from GAATTCGGGAGATCTTTGATTTTTGCAATCAGTGATACTTTGACAT
TCAGG; Q0, CCAGTGAGCAGAGTGACG; Q1, GACTCGAGCTCAdifferences in primary sequence and manifested as a
AGCTAA; AP-1, CCATCCTAATACGACTCACTATAGGGC; AP-2, ACbarrier to cross-species prion induction, could serve
TCACTATAGGGCTCGAGCGGC.as mechanism to prevent such improper interactions.
Consistent with the proposal that multiple prion states
Cloning of Foreign SUP35p PrDscould propagate independently in the same cell, we
To clone Sup35 PrDM domains, we modified the RACE procedure
have identified a novel prion-forming domain in S. cere- for capturing cDNA 59 ends (Frohman, 1993) to allow analysis of
visiae (the N-terminal portion of New1p) and have shown genomic DNA. Yeast genomic DNA from the desired species was
digested to completion by a restriction enzyme that results in eitherthat its prion state propagates independently of [PSI1].
59 GATC overhangs or blunt ends. Linkers compatible with eitherFurthermore, we find that overexpression of a Ure2p
the GATC (annealed P12, P13) or blunt ends (annealed P14, P15)fragment that efficiently induces the [URE3] prion (Ed-
were then ligated onto the ends of the genomic fragments. PCRskes et al., 1999) does not induce [PSI1] nor is Ure2p
amplification was performed using the ligated fragments as tem-
incorporated into [PSI1] aggregates (data not shown), plates, the EF-specific primer P10 and linker primer Q0 or AP1 for
indicating that the existence of one prion within a cell the GATC or blunt ended fragments, respectively. Amplified prod-
ucts were used as templates in a second round of PCR using nesteddoes not promote the appearance of others.
EF-specific primer P11 and linker primer Q1 or AP2 for the GATCIf multiple different prions can exist independently
and blunt-ended derived fragments, respectively. For reactions re-within a single cell, then how many different prions are
sulting in a single distinct band, PCR products were purified bythere? The spectrum of Sup35p PrD sequences, to-
agarose gel electrophoresis and sequenced.
gether with earlier mutational analyses, provide a wealth
of data to search for novel prions. Despite little strict Plasmid Construction
sequence conservation, all of the examined Sup35p All yeast expression vectors used a previously described (DePace
et al., 1998) modular insert composed of a promoter domain flankedPrDs as well as the Ure2p prion domain contain an
by 59 Xho1 and 39 BamHI sites, a PrDM/New1p1±153 domain flankedextremely high Gln/Asn and low charge content (Figures
by 59 BamHI/Sal1 and 39 BglII/EcoRI sites, and an EF/GFP/eCFP/1B and 7A). Moreover, in some neurodegenerative dis-
eYFP domain flanked by 59 EcoRI and 39 SacI sites. For the main-eases, expansion of polyGln repeats leads to intra-
tainer plasmid, the insert was cloned into the XhoI±SacI sites of an
nuclear aggregates in vivo and self-propagating amy- URA3 marked CEN/ARS plasmid (pRS316), and a triple HA epitope
loids in vitro (for review, see Bates et al., 1998). A search was inserted between the BglII/EcoRI sites. For the inducer plas-
mids, the insert was cloned into the XhoI±SacI sites of a LEU2-of genomic databases for domains with amino acid con-
marked 2 mm plasmid (pRS425). To create the foreign PrDM inducertent comparable to Sup35p PrDs revealed a handful of
and maintainer plasmids, PrDMCA (primers P1, P2), PrDMPM (P3, P4),such domains in both yeast and nematodes (Figure 7A
or PrDMKL (P5, P6) domains were PCR-amplified from genomic DNAand M. Michelitsch and J. S. W., unpublished data) at
and inserted into the BamHI/EcoRI sites of the appropriate PrDMSCleast one of which (New1p) forms a prion in yeast. The encoding plasmid. To create the New1p inducer and maintainer
challenge now is to determine how many other Gln/Asn- plasmids, the first 153 codons of NEW1 were PCR amplified (P16
and P17) and inserted into the Sal1/EcoR1 sites of the appropriaterich domains can form stable, self-propagating prions
PrDMSC encoding plasmid. The chimeras PrDMSC1-39CA (encoding aand what the physiological role for such novel prions
protein in which residues 40±124 of PrDMSC were replaced withmay be.
residue 44±140 from PrDMCA), PrDMCA1-39SC (encoding a protein in
which residue 1±39 of PrDMSC was replaced with residue 1±44 of
PrDMCA), and PrDMSC8-26CA (encoding a protein in which residues 1±7Experimental Procedures
and 27±124 of PrDMSC were replaced with residues 1±7 and 30±140
from PrDMCA, respectively) were all derived from the PrDMSC inducerGeneral Procedures and Reagents
plasmid by seamless cloning (Stratagene). Plasmids encoding eCFPIsogenic S. cerevisiae [psi2] and [PSI1] strains 74-D694 [Mata, ade1-
and eYFP were obtained from Clontech. For bacterial expression,14(UGA), his3, leu2, trp1, ura3] (Chernoff et al., 1995) were used for
63 His±tagged PrDMCA with (P7, P9) or without (P7, P8) an HAall experiments except the Sup35p deletion studies, which used
tag was PCR amplified and inserted into NdeI/EcoRI sites of a T7YJW541 [Mata, ade1-14, his3, leu2, trp1, ura3, sup35::TRP1]. C.
expression vector.albicans SC5314, K. marxianus, and P. pastoris were gifts from A.
Johnson, E. Blackburn, and C. Craik, respectively. K. lactis and S.
In Vivo GFP Foci Formationludwigii were gifts from I. Herskowitz. P. methanolica (56509) and
Yeast carrying the indicated species of PrDM-GFP inducer plasmidZ. rouxi (48232) were obtained from ATCC. Nucleic acid, immu-
were grown to early log phase in SD-LEU and induced with 50noblot, and yeast manipulations were performed according to stan-
mM CuSO4. At indicated times, cells were examined by fluorescentdard protocols (Ausubel, 1987). All plasmid sequences were con-
microscopy (Olympus B360) and photographed by CCD camerafirmed by dye termination sequencing (Perkin-Elmer).
(Photometrics). For quantitative measurement, random fields wereOligonucleotide primers were as follows: P1, GGGGGATCCGT
chosen and percentage of fluorescent cells with punctate foci wereCGACACTAGTACAATGTCTGACCAACAGAATACT; P2, CCCAGAT
calculated. Double fluorescence images were collected by wide-CTTCTAGAATCCTTGACAACTTCTTCGTC; P3, GGGGGATCCGTC
field 3D deconvolution microscopy (Agard et al., 1989) using filtersGACACTAGTACAATGTCTCAAGATCAACAGCAA; P4, CCCAGATC
optimized for CFP and YFP fluorescence (Chroma).TTCTAGAATCGTTGACAATGGAGGCATC; P5, CGACGAGGATCCG
TCGACATGTCAGACCAACAAAATCAAGACCAAGGG; P6, CAAAG
TGAATTCAGATCTATCTTTAACGACTTCTTC; P7, GGGCGGCATAT [PSI1] Conversion Assay and Two-Plasmid Assay
for AggregationGTCTGACCAACAGAATACTCAG; P8, GCCCGAATTCTTAGTGATGA
TGGTGATGGTGGTGATCCTTGACAACTTCTTCGTC; P9, CCGGAA For [PSI1] conversion assay, [psi2] yeast freshly transformed with
the indicated inducer plasmids were grown in 10 ml SD-LEU to earlyTTCTTAATGGTGATGATGGTGATGAGCGTAATCTGGAACGTCATA;
P10, AACGGTTGGGTCATCCATCTT; P11, TTTGTTGGTATCCAT log phase and induced with 50 mM CuSO4. After 24 hr, samples
Molecular Basis of a Yeast Prion Species Barrier
287
were plated onto SD-ADE. For the two-plasmid [CHI1] conversion for amyloid formation in the prion diseases: importance of seeding.
Proc. Natl. Acad. Sci. USA 90, 5959±5963.assay, [PSI1] yeast freshly transformed with the indicated species
of maintainer and inducer plasmids were grown in 10 ml SD-URA- DePace, A.H., Santoso, A., Hillner, P., and Weissman, J.S. (1998).
LEU to early log phase and induced with 50 mM CuSO4. At indicated A critical role for amino-terminal glutamine/asparagine repeats in
times, samples were plated onto SD-URA-ADE. For both assays, the formation and propagation of a yeast prion. Cell 93, 1241±1252.
after 5 days incubation at 308C, visible colonies were counted. For Derkatch, I.L., Chernoff, Y.O., Kushnirov, V.V., Inge-Vechtomov,
the [CHI1] induction experiments in the sup35 deletion strain, S.G., and Liebman, S.W. (1996). Genesis and variability of [PSI] prion
YJW541 initially carrying p316SpSupEF (Depace et al, 1998) and a factors in Saccharomyces cerevisiae. Genetics 144, 1375±1386.
HIS-marked PrDMCA-EF maintainer plasmid were grown on 5-FOA
Doel, S.M., McCready, S.J., Nierras, C.R., and Cox, B.S. (1994).to ensure loss of p316SpSupEF yielding the [psi8 chi2] strain. The
The dominant PNM2- mutation which eliminates the psi factor of[psi8 CHI1] was derived by transient overexpression of PrDMCA from
Saccharomyces cerevisiae is the result of a missense mutation inan inducer plasmid, selection on medium lacking ADE and subse-
the SUP35 gene. Genetics 137, 659±670.quent loss of inducer plasmid. For the [NU1] induction experiments,
Eaglestone, S.S., Cox, B.S., and Tuite, M.F. (1999). Translation termi-[PSI1] yeast freshly transformed with the New1p inducer and main-
nation efficiency can be regulated in Saccharomyces cerevisiae bytainer plasmids and treated as described above for the [CHI1] exper-
environmental stress through a prion-mediated mechanism. EMBOiments.
J. 18, 1974±1981.
Immunoelectron Microscopy Edskes, H., Gray, V.T., and Wickner, R.B. (1999). The (URE3) prion
PrDM fibrils (8 mg) produced from a conversion reaction containing is an aggregated form of Ure2p that can be cured by overexpression
equimolar PrDMSC and PrDM-HACA were incubated with 50 mg rabbit of Ure2p fragments. Proc. Natl. Acad. Sci. USA 96, 1498±1503.
polyclonal antibody raised against PrDMSC (HTI Bio-products) and Frohman, M.A. (1993). Rapid amplification of complementary DNA
100 mg of the mouse monoclonal anti-HA antibody 16B12 (Babco) ends for generation of full-length complementary DNAs: thermal
for 20 min at room temperature. Five microliters each of 5 nm gold RACE. Meth. Enzymol. 218, 340±356.
conjugated to anti-rabbit and 15 nm gold conjugated anti-mouse
Glover, J.R., Kowal, A.S., Schirmer, E.C., Patino, M.M., Liu, J.J., and
secondary antibodies (Nanoprobes) were added and incubated for
Lindquist, S. (1997). Self-seeded fibers formed by Sup35, the protein
an additional 20 min. The solution was added to a glow discharged
determinant of [PSI1], a heritable prion-like factor of S. cerevisiae.
carbon coated nickel grid, washed extensively with water, and
Cell 89, 811±819.
stained with 2% uranyl acetate. Electron micrographs were col-
Han, H., Weinreb, P.H., and Lansbury, P.T., Jr. (1995). The corelected with EM400 Transmission Electron Microscope (Phillips).
Alzheimer's peptide NAC forms amyloid fibrils which seed and are
seeded by beta-amyloid: is NAC a common trigger or target inOther Assays
neurodegenerative disease? Chem. Biol. 2, 163±169.Centrifugation assays were performed as previously described (De-
Higgins, D.G., Thompson, J.D., and Gibson, T.J. (1996). Using CLUS-Pace et al., 1998). Recombinant PrDM was purified under denaturing
TAL for multiple sequence alignments. Meth. Enzymol. 266,conditions as described previously (Glover et al., 1997; DePace et
383±402.al., 1998). Congo red binding assays were carried out as described
previously (DePace et al., 1998). Horiuchi, M., and Caughey, B. (1999). Specific binding of normal
prion protein to the scrapie form via a localized domain initiates its
Acknowledgments conversion to the protease-resistant state. EMBO J. 18, 3193±3203.
Ito, K., Ebihara, K., and Nakamura Y. (1998). The stretch of C-terminal
We thank Y. Chernoff, I. Herskowitz, E. O'Shea, J. Reddy, and mem- acidic amino acids of translational release factor eRF1 is a primary
bers of the Weissman lab for helpful discussion, Paul Herzmark for binding site for eRF3 of fission yeast. RNA 4, 958±972.
help with fluorescence microscopy, and M. Michelitsch for help with
King, C.Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M., and
sequence analysis. This work was supported by the Searle Scholars
WuÈ thrich, K. (1997). Prion-inducing domain 2±114 of yeast Sup35
Program, the David and Lucile Packard Foundation, the NIH, an
protein transforms in vitro into amyloid-like filaments. Proc. Natl.
NSF Predoctoral Fellowship (P. C.), and an HHMI Predoctoral Fel-
Acad. Sci. USA 94, 6618±6622.
lowship (L. Z. O.).
Kocisko, D.A., Priola, S.A., Raymond, G.J., Chesebro, B., Lansbury,
P.T., Jr., and Caughey, B. (1995). Species specificity in the cell-freeReceived September 13, 1999; revised December 14, 1999.
conversion of prion protein to protease-resistant forms: a model for
the scrapie species barrier. Proc. Natl. Acad. Sci. USA 92, 3923±References
3927.
Koo, E.H., Lansbury, P.T., Jr., and Kelly, J.W. (1999). Amyloid dis-Agard, D.A., Hiraoka, Y., Shaw, P., and Sedat, J.W. (1989). Fluores-
eases: abnormal protein aggregation in neurodegeneration. Proc.cence microscopy in three dimensions. Methods Cell Biol. 30,
Natl. Acad. Sci USA 96, 9989±9990.353±377.
Kurtzman, C.P. (1994). Molecular taxonomy of the yeasts. Yeast 10,Ausubel, F.M. (1987). Current protocols in molecular biology (New
1727±1740.York: Greene Pub. Associates and Wiley-Interscience).
Kushnirov, V.V., Ter-Avanesyan, M.D., Didichenko, S.A., Smirnov,Bailleul, P.A., Newnam, G.P., Steenbergen, J.N., and Chernoff, Y.O.
V.N., Chernoff, Y.O., Derkach, I.L., Novikova, O.N., Inge-Vechtomov,(1999). Genetic study of interactions between the cytoskeletal as-
S.G., Neistat, M.A., and Tolstorukov, I.I. (1990). Divergence and con-sembly protein Sla1 and prion-forming domain of the release factor
servation of SUP2 (SUP35) gene of yeast Pichia pinus and Saccharo-Sup35 (eRF3) in Saccharomyces cerevisiae. Genetics 153, 81±94.
myces cerevisiae. Yeast 6, 461±472.Bates, G.P., Mangiarini, L., Wanker, E.E., and Davies, S.W. (1998).
Lansbury, P.T., Jr. (1999). Evolution of amyloid: what normal proteinPolyglutamine expansion and Huntington's disease. Biochem. Soc.
folding may tell us about fibrillogenesis and disease. Proc. Natl.Trans. 26, 471±475.
Acad. Sci. USA 96, 3342±3344.Chernoff, Y.O., Derkach, I.L., and Inge-Vechtomov, S.G. (1993).
Lindquist, S. (1997). Mad cows meet psi2chotic yeast: the expansionMulticopy SUP35 gene induces de-novo appearance of psi2like
of the prion hypothesis. Cell 89, 495±498.factors in the yeast Saccharomyces cerevisiae. Curr. Genet. 24,
268±270. Liu, J.J., and Lindquist, S. (1999). Oligopeptide-repeat expansions
modulate `protein-only' inheritance in yeast. Nature 400, 573±576.Chernoff, Y.O., Lindquist, S.L., Ono, B., Inge-Vechtomov, S.G., and
Liebman, S.W. (1995). Role of the chaperone protein Hsp104 in Patino, M.M., Liu, J.J., Glover, J.R., and Lindquist, S. (1996). Support
for the prion hypothesis for inheritance of a phenotypic trait in yeast.propagation of the yeast prion-like factor [psi1]. Science 268,
880±884. Science 273, 622±626.
Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan,Come, J.H., Fraser, P.E., and Lansbury, P.T. (1993). A kinetic model
Cell
288
M.D. (1996). Propagation of the yeast prion-like [psi1] determinant
is mediated by oligomerization of the SUP35-encoded polypeptide
chain release factor. EMBO J. 15, 3127±3134.
Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan,
M.D. (1997). In vitro propagation of the prion-like state of yeast
Sup35 protein. Science 277, 381±383.
Prusiner, S.B., Scott, M.R., DeArmond, S.J., and Cohen, F.E. (1998).
Prion protein biology. Cell 93, 337±348.
Sunde, M., and Blake, C. (1997). The structure of amyloid fibrils by
electron microscopy and X-ray diffraction. Adv. Protein Chem. 50,
123±159.
Telling, G.C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M.,
Cohen, F.E., DeArmond, S.J., and Prusiner, S.B. (1995). Prion propa-
gation in mice expressing human and chimeric PrP transgenes impli-
cates the interaction of cellular PrP with another protein. Cell 83,
79±90.
Ter-Avanesyan, M.D., Kushnirov, V.V., Dagkesamanskaya, A.R., Di-
dichenko, S.A., Chernoff, Y.O., Inge-Vechtomov, S.G., Smirnov, V.N.
(1993). Deletion analysis of the SUP35 gene of the yeast Saccharo-
myces cerevisiae reveals two non-overlapping functional regions in
the encoded protein. Mol. Microbiol. 7, 683±692.
Tuite, M.F., Mundy, C.R., and Cox, B.S. (1981). Agents that cause
a high frequency of genetic change from [psi1] to [psi2] in Saccharo-
myces cerevisiae. Genetics 98, 691±711.
Wickner, R.B. (1994). [URE3] as an altered URE2 protein: evidence
for a prion analog in Saccharomyces cerevisiae. Science 264,
566±569.
Wickner, R.B., Masison, D.C., and Edskes, H.K. (1995). [PSI] and
[URE3] as yeast prions. Yeast 11, 1671±1685.
Zhou, P., Derkatch, I.L., Uptain, S.M., Patino, M.M., Lindquist, S.,
and Liebman, S.W. (1999). The yeast non-Mendelian factor [ETA1]
is a variant of [PSI1], a prion-like form of release factor eRF3. EMBO
J. 18, 1182±1191.
GenBank Accession Numbers
The GenBank accession numbers for the sequences reported in this
paper are as follows: Z. rouxii, AF206292; S. ludwigii, AF206291; P.
pastoris, AF206290; K. marxianus, AF206289; K. lactis, AF206288;
C. albicans, AF206287.
